Quantcast

Latest European Medicines Agency Stories

2015-04-24 08:30:39

- HETLIOZ®, a circadian regulator, is the first and only product to receive a recommendation for approval for Non-24 in the European Union WASHINGTON, April 24, 2015 /PRNewswire/

2015-04-24 04:23:02

- Hospira calls for continued support of extrapolation principle to help drive increased patient access to life-saving biologic medicines - LONDON, April 24, 2015 /PRNewswire/ --

2015-04-16 23:00:38

The Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce the participation of high-level representatives from the U.S.

2015-03-25 08:30:05

CALGARY, March 25, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.

2015-03-23 04:21:47

BANGALORE, March 23, 2015 /PRNewswire/ -- - The First Stem Cell Drug Based on Pooling Technology to be Granted ATMP Classification - A New Treatment Which

2015-03-16 12:27:29

NESS ZIONA, Israel, March 16, 2015 /PRNewswire/ -- - Recognition of the unmet medical need and high therapeutic potential of ImMucin in Multiple

2015-03-13 08:26:21

If authorized, SB2 will be marketed in Europe by Biogen Idec INCHEON, South Korea, March 13, 2015 /PRNewswire/ -- Samsung Bioepis Co., Ltd., today announced that the Marketing Authorization

2015-03-02 12:31:24

MONT-SAINT-GUIBERT, Belgium, March 2, 2015 /PRNewswire/ -- Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), a leader in the discovery and development of specialized cell

2015-03-02 08:31:25

STOCKLEY PARK, London, March 2, 2015 /PRNewswire/ -- Taiho Pharma Europe Ltd., a subsidiary of Japan based Taiho


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related